Detalles de la búsqueda
1.
Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence.
Int J Infect Dis
; 144: 107047, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609035
2.
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Vaccine
; 42(2): 383-395, 2024 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061956
3.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Vaccine
; 41(31): 4541-4553, 2023 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330371
4.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Vaccine
; 40(15): 2352-2361, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789403
5.
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines.
EClinicalMedicine
; 37: 100976, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34386749
Resultados
1 -
5
de 5
1
Próxima >
>>